165 related articles for article (PubMed ID: 9055206)
21. Leukocyte-derived growth factor links the PDGF and CXC chemokine families of peptides.
Iida N; Haisa M; Igarashi A; Pencev D; Grotendorst GR
FASEB J; 1996 Sep; 10(11):1336-45. PubMed ID: 8836048
[TBL] [Abstract][Full Text] [Related]
22. Chemokine regulation of human megakaryocytopoiesis.
Gewirtz AM; Zhang J; Ratajczak J; Ratajczak M; Park KS; Li C; Yan Z; Poncz M
Blood; 1995 Oct; 86(7):2559-67. PubMed ID: 7670101
[TBL] [Abstract][Full Text] [Related]
23. Mast cells and neutrophils proteolytically activate chemokine precursor CTAP-III and are subject to counterregulation by PF-4 through inhibition of chymase and cathepsin G.
Schiemann F; Grimm TA; Hoch J; Gross R; Lindner B; Petersen F; Bulfone-Paus S; Brandt E
Blood; 2006 Mar; 107(6):2234-42. PubMed ID: 16317101
[TBL] [Abstract][Full Text] [Related]
24. Cloning of cDNA coding for connective tissue activating peptide III from a human platelet-derived lambda gt11 expression library.
Wenger RH; Wicki AN; Walz A; Kieffer N; Clemetson KJ
Blood; 1989 May; 73(6):1498-503. PubMed ID: 2713489
[TBL] [Abstract][Full Text] [Related]
25. Limited and defined truncation at the C terminus enhances receptor binding and degranulation activity of the neutrophil-activating peptide 2 (NAP-2). Comparison of native and recombinant NAP-2 variants.
Ehlert JE; Petersen F; Kubbutat MH; Gerdes J; Flad HD; Brandt E
J Biol Chem; 1995 Mar; 270(11):6338-44. PubMed ID: 7890771
[TBL] [Abstract][Full Text] [Related]
26. Platelet-derived chemokines CXC chemokine ligand (CXCL)7, connective tissue-activating peptide III, and CXCL4 differentially affect and cross-regulate neutrophil adhesion and transendothelial migration.
Schenk BI; Petersen F; Flad HD; Brandt E
J Immunol; 2002 Sep; 169(5):2602-10. PubMed ID: 12193731
[TBL] [Abstract][Full Text] [Related]
27. Connective tissue activation. XXXV. Detection of connective tissue activating peptide-III isoforms in synovium from osteoarthritis and rheumatoid arthritis patients: patterns of interaction with other synovial cytokines in cell culture.
Castor CW; Smith EM; Hossler PA; Bignall MC; Aaron BP
Arthritis Rheum; 1992 Jul; 35(7):783-93. PubMed ID: 1622417
[TBL] [Abstract][Full Text] [Related]
28. The CXC-chemokine neutrophil-activating peptide-2 induces two distinct optima of neutrophil chemotaxis by differential interaction with interleukin-8 receptors CXCR-1 and CXCR-2.
Ludwig A; Petersen F; Zahn S; Götze O; Schröder JM; Flad HD; Brandt E
Blood; 1997 Dec; 90(11):4588-97. PubMed ID: 9373270
[TBL] [Abstract][Full Text] [Related]
29. Lipopolysaccharide-stimulated human monocytes secrete, apart from neutrophil-activating peptide 1/interleukin 8, a second neutrophil-activating protein. NH2-terminal amino acid sequence identity with melanoma growth stimulatory activity.
Schröder JM; Persoon NL; Christophers E
J Exp Med; 1990 Apr; 171(4):1091-100. PubMed ID: 2182761
[TBL] [Abstract][Full Text] [Related]
30. Connective tissue activation. XXXVI. The origin, variety, distribution, and biologic fate of connective tissue activating peptide-III isoforms: characteristics in patients with rheumatic, renal, and arterial disease.
Castor CW; Andrews PC; Swartz RD; Ellis SG; Hossler PA; Clark MR; Matteson EL; Sachter EF
Arthritis Rheum; 1993 Aug; 36(8):1142-53. PubMed ID: 8343190
[TBL] [Abstract][Full Text] [Related]
31. Connective tissue activation. XXXII. Structural and biologic characteristics of mesenchymal cell-derived connective tissue activating peptide-V.
Cabral AR; Cole LA; Walz DA; Castor CW
Arthritis Rheum; 1987 Dec; 30(12):1393-400. PubMed ID: 3124861
[TBL] [Abstract][Full Text] [Related]
32. Generation of the neutrophil-activating peptide-2 by cathepsin G and cathepsin G-treated human platelets.
Cohen AB; Stevens MD; Miller EJ; Atkinson MA; Mullenbach G
Am J Physiol; 1992 Aug; 263(2 Pt 1):L249-56. PubMed ID: 1387511
[TBL] [Abstract][Full Text] [Related]
33. Increased microvascular permeability in vivo in response to intradermal injection of neutrophil-activating protein (NAP-2) in rabbit skin.
Van Osselaer N; Van Damme J; Rampart M; Herman AG
Am J Pathol; 1991 Jan; 138(1):23-7. PubMed ID: 1824807
[TBL] [Abstract][Full Text] [Related]
34. Relationship between neutrophil-binding affinity and suitability for infection imaging: comparison of (99m)Tc-labeled NAP-2 (CXCL-7) and 3 C-terminally truncated isoforms.
Rennen HJ; Frielink C; Brandt E; Zaat SA; Boerman OC; Oyen WJ; Corstens FH
J Nucl Med; 2004 Jul; 45(7):1217-23. PubMed ID: 15235069
[TBL] [Abstract][Full Text] [Related]
35. The neutrophil-activating proteins interleukin 8 and beta-thromboglobulin: in vitro and in vivo comparison of NH2-terminally processed forms.
Van Damme J; Rampart M; Conings R; Decock B; Van Osselaer N; Willems J; Billiau A
Eur J Immunol; 1990 Sep; 20(9):2113-8. PubMed ID: 2145175
[TBL] [Abstract][Full Text] [Related]
36. The beta-thromboglobulins and platelet factor 4: blood platelet-derived CXC chemokines with divergent roles in early neutrophil regulation.
Brandt E; Petersen F; Ludwig A; Ehlert JE; Bock L; Flad HD
J Leukoc Biol; 2000 Apr; 67(4):471-8. PubMed ID: 10770278
[TBL] [Abstract][Full Text] [Related]
37. Structural and biological characteristics of connective tissue activating peptide (CTAP-III), a major human platelet-derived growth factor.
Castor CW; Miller JW; Walz DA
Proc Natl Acad Sci U S A; 1983 Feb; 80(3):765-9. PubMed ID: 6572368
[TBL] [Abstract][Full Text] [Related]
38. Connective tissue activation. XXXIV: Effects of proteolytic processing on the biologic activities of CTAP-III.
Castor CW; Walz DA; Johnson PH; Hossler PA; Smith EM; Bignall MC; Aaron BP; Underhill P; Lazar JM; Hudson DH
J Lab Clin Med; 1990 Oct; 116(4):516-26. PubMed ID: 2212861
[TBL] [Abstract][Full Text] [Related]
39. Production of chemokines CTAPIII and NAP/2 by digestion of recombinant ubiquitin-CTAPIII with yeast ubiquitin C-terminal hydrolase and human immunodeficiency virus protease.
Mildner AM; Paddock DJ; LeCureux LW; Leone JW; Anderson DC; Tomasselli AG; Heinrikson RL
Protein Expr Purif; 1999 Jul; 16(2):347-54. PubMed ID: 10419831
[TBL] [Abstract][Full Text] [Related]
40. The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor.
Ahuja SK; Murphy PM
J Biol Chem; 1996 Aug; 271(34):20545-50. PubMed ID: 8702798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
